AAAdeseye Michael Akinsete

Adeseye Michael Akinsete

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adeseye Michael Akinsete has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities

    by Halima Bello‐Manga, Shehu Umar Abdullahi, Hoda Hassab, Biobele Brown, Videlis Nduba, Jessie Githanga, Adeseye Michael Akinsete, Amal El‐Beshlawy, Diana Hanna, Catherine Segbefia, et al.

    Children with SCD have elevated stroke risk, correlated with cerebral blood flow velocity (CBFV). HOPE Kids 2 was a phase 3, multicenter, double‐blind, placebo‐controlled trial evaluating the effect of voxelotor on CBFV. Participants aged 2 to < 15 years with SCD (HbSS/HbSβ 0 ) and conditional CBFV (170 to < 200 cm/s) were randomized 1:1 to voxelotor ( N = 120) or placebo ( N = 116) for 96 weeks; 195 (83%) were in sub‐Saharan Africa. The primary endpoint, CBFV change from baseline to Week 24, was significantly greater with voxelotor (least‐squares mean change: voxelotor [ n = 114] −12.06 cm/s, placebo [ n = 108] −4.29 cm/s; difference −7.77 cm/s; 95% CI −13.18 to −2.37; p = 0.0048), with significant difference sustained through Week 48. Hemoglobin levels increased at Weeks 24 and 48 with voxelotor. Drug administration was paused in May 2024 when an imbalance of deaths was observed between treatment groups; subsequently, the trial discontinued when all active voxelotor trials were discontinued in September 2024. At study end, median (range) exposure was 84 (3–104) weeks for voxelotor and 84 (3–106) weeks for placebo. The most common SCD‐related treatment‐emergent adverse event was sickle cell anemia with crisis (voxelotor 59.2%; placebo 37.9%). All deaths (voxelotor n = 8; placebo n = 2) were considered unrelated to study drug by treating investigators. Overall, voxelotor showed CBFV reduction in children with SCD and conditional CBFV, suggesting HbS polymerization inhibition has a potential therapeutic role for this group; nevertheless, additional studies evaluating potential regional risks for sickle cell anemia with crisis or mortality are warranted. Trial Registration: ClinicalTrials.gov identifier: NCT04218084


  • Open Access

    Pulmonary tuberculosis reactivation in a 4-year-old boy on treatment for acute lymphoblastic leukemia: a case report and review of literature

    by Ugonna Olaraiche Fakile, Adeseye Michael Akinsete, Adebola T. Damola-Okesiji, Onyinye Odimegwu, Ihunanyachukwu A. Obi, Elemo Olaide, Oladunni Okodugha, Edamisan O. Temiye

  • Open Access

    Pediatric Colorectal Cancer in Africa: A Multicenter Study on Epidemiology, Management, and Outcomes Between 2000 and 2023

    by Jaques van Heerden, Joyce Balagadde-Kambugu, Veronica Nyakato, Pamela Mwa, Fadhil Geriga, Barnabas Atwiine, Victoria Mwebe Katasi, Sarra Benmiloud, Laila Hessissen, Imène Chabchoub, et al.

    Introduction: Colorectal cancer (CRC) is increasing in Africa, yet reports in children and adolescents are limited. We describe the epidemiology, management, and survival outcomes of CRC in African children. Methods: Retrospective data of children under 19 years diagnosed with CRC between 2000 and 2023 were collected from 14 African countries. Patient and tumor characteristics and treatment data were described and survival outcomes analyzed. GLOBOCAN data were used to evaluate age‐related geographical distribution of CRC. Results: Hundred‐and‐eight patients, 57.4% males, were diagnosed with a mean age of 14.9 (range 5–18) years. The mean symptom‐onset‐to‐diagnosis duration was 90 days (range 2–1200). Most common symptoms were abdominal discomfort (70.6%) and change in bowel habits (57.8%). The commonest primary site was the ascending colon (30.6%) with a mean tumor size of 64.3 mm (range 30–150 mm) and 37% presenting in stage III and 36.1% in stage IV. Most (83.3%) tumors were confirmed on histology, of which 78.7% were adenocarcinoma. Carcinoembryonic antigen was performed in 38.9% of patients. Complete resection was achieved in 55.6% of cases, while 18.5% received radiotherapy. Folinic acid, Fluorouracil, Oxaliplatin (FOLFOX) was the first line chemotherapy in 48.1% of patients. A third of patients were lost to follow‐up while 25.6% experienced disease progression. The 2‐year and 5‐year overall survival rates were 40.0% and 16.9%, respectively. Disease stage ( p = 0.07) and degree of resection ( p = 0.02) predicted outcomes. Conclusion: Pediatric CRC is characterized by delayed diagnosis and advanced stage presentation, contributing to a significantly lower overall survival compared to adults. Focused research and multidisciplinary management are needed to understand pediatric CRC and improve outcomes.

    • 30 April 2026
      • Vol. 43  (1) , 53-57

    Whispers from a Hollow Place: Caregiver Experiences Following Childhood Cancer Survival in Lagos State: A Qualitative Study.

    by A M Akinsete, U O Fakile, O Adisa, B O James, A O Joseph, A Damola-Okesiji, B Quadri, K Akindele, E O Temiye

    As childhood cancer survival improves globally, increasing attention is directed toward the emotional and social challenges faced by families, especially caregivers. However, in low- and middle-income countries such as Nigeria, caregivers' coping experiences remain underexplored despite extensive documentation in high-income settings. To explore the psychosocial and health-related experiences of caregivers of childhood cancer survivors after treatment completion in Lagos, Nigeria, focusing on their coping strategies, emotional responses, and perceived family impact. A qualitative descriptive design was employed, with 15 caregivers of childhood cancer survivors recruited through purposive sampling. Data collection combined semi-structured focus group discussions with standardized assessments, including the Hospital Anxiety and Depression Scale (HADS), the PTSD Checklist for DSM-5 (PCL-5), and the Connor-Davidson Resilience Scale (CD-RISC). Discussions were audio-recorded, transcribed verbatim, and thematically analyzed using Braun and Clarke's six-phase framework. The analysis revealed three key themes: (1) Physical Consequences, including loss of employment, reduced work efficiency, and financial hardship; (2) Emotional Strain, marked by symptoms of PTSD, feelings of helplessness, and anxiety about potential relapses; and (3) Social Adjustments, such as improved health-seeking behaviours and stronger family relationships. Among participants, 60% demonstrated high levels of resilience, while 73% showed signs of anxiety, and the same proportion exhibited PTSD-related symptoms. All three male caregivers reported experiencing PTSD symptoms. Caregivers of childhood cancer survivors in Lagos experience notable physical and emotional strain, including symptoms of anxiety and PTSD. Despite minimal formal support, many adapt through strengthened family ties, improved health practices, and spiritual traditions. These results suggest a need for culturally sensitive, caregiver-focused support within survivorship care. Further research should guide the development of targeted interventions in low-resource settings. Caregivers of childhood cancer survivors in Lagos continue to experience significant psychosocial burdens beyond active treatment. There is an urgent need for structured psychosocial support integrated into survivorship care plans, especially in LMIC contexts.

  • Open Access

    Serum magnesium levels of children living with sickle cell anaemia at the Lagos University Teaching Hospital: a comparative cross-sectional study

    by Pauline Kasarachi Akowundu, Abideen Olurotimi Salako, Adeseye Michael Akinsete, Patricia Akintan

    Background: Sickle cell anaemia (SCA) is a lifelong, chronic haemolytic disorder with episodic vaso-occlusive crises (VOC) and chronic end-organ damage. Red cell dehydration during a VOC changes permeability with loss of potassium and magnesium. Magnesium has been found to act via both Gardos and K-Cl channels, preventing red cell dehydration and reducing the propensity for sickling. This study assessed serum magnesium levels in children living with SCA in steady state and crisis, and the relationship between serum magnesium levels and severity of pain in VOC. Methods: A comparative cross-sectional study involving age- and gender-matched 180 children living with SCA aged 1–18 years (90 in VOC and steady state, respectively). The severity of pain was assessed using standard pain tools (FLACC and Wong-Baker FACES Pain scale), and a blood sample was taken for magnesium assay using the colorimetry method of analysis. Categorical variables were presented as frequencies and percentages. Comparison of means between the two groups and according to magnesium status was carried out using an independent Student's t-test. Results: The mean age of participants in VOC and steady state was 8.49 ± 2.4 years and 8.62 ± 2.0 years, respectively. The mean serum magnesium of subjects in VOC was significantly higher compared to the steady state (0.85 ± 0.1 vs 0.83 ± 0.1 mmol/l, p = 0.032). The moderate to severe pain was the most common pain (63.3%), and the average serum magnesium was higher in the group with moderate to severe pain, but the difference was not statistically significant across the three groups ( p = 0.315). Conclusion: VOC maybe associated with elevated serum magnesium in SCA.

  • Open Access

    The Landscape of Pediatric Radiation Oncology in Nigeria

    by Adedayo Joseph, Adeseye M. Akinsete, Nwamaka N. Lasebikan, Samuel Adeneye, Opeyemi M. Awofeso, Aishat T. Oladipo, Azeezat O. Ajose, Oluwatimileyin Ojo, Kenneth Merrell, Wilfred Ngwa, et al.

    Radiation therapy (RT) is an essential part of the multidisciplinary treatment of pediatric cancer. Over the past five decades, significant advances have been made in the delivery of RT, with better dose delivery to disease targets while minimizing exposure to nearby organs at risk. These advances have led to improved treatment outcomes, increased survival, and reduced treatment-related toxicities. Advanced treatment techniques, however, require significant investment in infrastructural and personnel resources. This review documents what is currently available regarding expertise and infrastructure for pediatric radiation oncology practice in Nigeria. It was performed to serve as a foundation for the creation and design of tailored solutions (initiatives and policies) to increase pediatric radiation availability, accessibility, and equity in Nigeria and ultimately improve pediatric cancer treatment outcomes in the region.


  • Open Access

    A Comparative Analysis of Hydroxyurea Treatment on Coagulation Profile Among Sickle Cell Anaemia Children in Lagos, Nigeria

    by Blessing E. Kene-Udemezue, Abideen O. Salako, Adeseye M. Akinsete, Oluwatosin O. Odubela, Titilope A. Adeyemo

    Background: Hydroxyurea (HU) is a disease‐modifying therapy with significant clinical and laboratory efficacy among individuals living with sickle cell anaemia (SCA). This is evident through increased fetal haemoglobin, higher packed cell volume, improved red cell hydration, reduced leukocytes, and platelet function. The effect on the coagulation pathway and pathophysiologic mechanism remains unclear, especially in children living with SCA. This study evaluated the coagulation profile using D‐dimer and thrombin antithrombin complex (TAT) in children with SCA.Methods: The cross‐sectional study was conducted over three months at LUTH among 80 children living with SCA in steady state aged 2–18 years (40 HU exposed and 40 HU naïve, respectively). Blood samples were assayed for D‐dimer, TAT, and complete blood count. Descriptive analysis such as mean and standard deviation for normally distributed variables or median and interquartile range for skewed data were used to summarize continuous variables, while proportion or percentages for categorical variables. Univariate analysis and bivariate analysis were done and statistical significance was set at p < 0.05.Results: The mean age (±SD) of study participants in both groups was 11.35 (±4.6 years). D‐dimer levels (23.27 ng/mL) and TAT (29.79 pg/mL) were significantly lower among HU exposed compared to HU naïve children (62.73 ng/mL and 109.34 pg/mL, respectively) p < 0.001. There was a negative correlation between D‐dimer and TAT with the duration of HU use (r = −0.499, p = 0.001, and r = −0.401, p = 0.010), respectively. There was a positive correlation between D‐dimer and TAT with total WBC (r = 0.368, p = 0.019, and r = 0.385, p = 0.014, respectively) among the HU naïve participants and a negative correlation between D‐dimer and TAT with haemoglobin level (r = −0.303, p = 0.047, and r = −0.311, p = 0.041, respectively) among HU exposed children.Conclusion: HU modulates the D‐dimer and TAT levels of children living with SCA toward the normal reference range, thus reducing the risk of hypercoagulability and associated sequelae. Therefore, continuous advocacy for HU use should entail close monitoring of adverse effects.


  • Open Access

    Pediatric Oncology in Nigeria: A Panoramic View

    by Adeseye Michael Akinsete, Babatunde Adeniran Odugbemi, Gbemisola Eniola Ogundowole, Uchechukwu Udochukwu Anene-Nzelu, Edamisan Temiye, Adebola Akinsulie

    PURPOSE: A large number of children still die as a result of cancer in low- to middle-income countries, and factors such has poor infrastructure, inadequate human resources, and poorly developed health insurance are responsible for most of these deaths. Nigeria is a country with a young population and a struggling health system. We aimed to survey pediatric oncologists in Nigeria using an online survey instrument. METHODS: We surveyed the national group of pediatric oncologists using an instrument designed to assess manpower availability, infrastructural support, support services, and presence of radiotherapy and medications. RESULTS: A total of 14 institutions responded, represented by 24 oncologists of the 42 oncologists on the platform, with a response rate of 57.1%. Most of the oncologists had practiced for more than 10 years, but only two institutions had a dedicated pediatric oncology ward. There was no population-based pediatric oncology tumor registry. Molecular diagnostic capability was not available, nor was a structurally efficient radiotherapy support service. The centers also struggled with inadequate blood and blood product provision. CONCLUSION: Pediatric oncology services in Nigeria are still grappling with weak human capital, poorly developed infrastructure, weak regional and national referral systems, and poor support services.


  • T-cell deplete versus T-cell replete haploidentical hematopoietic stem cell transplantation for sickle cell disease: where are we?

    by Dilan A. Patel, Adeseye M. Akinsete, James A. Connelly, Adetola A. Kassim

    Introduction: Severe sickle cell disease is associated with progressive end-organ damage and early mortality in adults. While allogeneic hematopoietic cell transplant from a matched related donor is curative, the vast majority of patients do not have a compatible sibling. Accordingly, platforms using haploidentical donors have been developed, which provide near-universal availability. Areas covered: This review focuses on the two commonly used approaches for haploidentical hematopoietic transplants, namely T-cell deplete and T-cell replete, each of which is associated with unique benefits and drawbacks. The purpose of this paper is to facilitate individualized decision-making for patients and providers by reviewing the pros- and cons of these differing approaches. Expert opinion: Individuals with sickle cell disease eligible for a hematopoietic cell transplant can be considered based on recent results. Comparable outcomes are seen with T-cell deplete and T-cell replete approaches. The choice depends largely on institutional preference.


  • Open Access

    Spectrum of Thyroid Abnormalities among Children Living with HIV in Lagos, Nigeria

    by Adeseye Akinsete, Elizabeth Oyenusi, Babatunde Odugbemi, Tinuola Odugbemi, Edamisan Temiye

    Thyroid disorders have been described in an adult population but are underreported in the pediatric population. The aim of this study was to determine the prevalence and describe the spectrum of thyroid abnormalities among HIV infected children on Highly Active Antiretroviral Therapy (HAART) in Lagos, Nigeria. This was a cross-sectional study carried out at a teaching hospital with an antiretroviral therapy (ART) center. Serum levels of thyroid stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4) were analyzed in 83 children living with HIV on HAART and 51 controls. The prevalence of thyroid dysfunction and correlation of fT3, fT4, and TSH with duration on HAART, age, CD4 count, and nutritional status were assessed. Thyroid abnormalities were seen in 9.6% of the children living with HIV comprising subclinical hypothyroidism in 6%, euthyroid sick syndrome in 2.4%, and overt hypothyroidism in 1.2% as compared to 2% subclinical thyroid disease among the controls (p= 0.15). Hypothyroidism was correlated with CD4 count and viral load. None of the patients had clinical features of thyroid disease. Thyroid abnormalities were more prevalent among children living with HIV and yearly screening with follow-up is advocated.